Peapod Lane Capital LLC Aadi Bioscience, Inc. Transaction History
Peapod Lane Capital LLC
- $88.9 Billion
- Q1 2025
A detailed history of Peapod Lane Capital LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 241,403 shares of AADI stock, worth $412,799. This represents 0.48% of its overall portfolio holdings.
Number of Shares
241,403
Previous 442,942
45.5%
Holding current value
$412,799
Previous $1.4 Billion
69.25%
% of portfolio
0.48%
Previous 1.39%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.5MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$4.87 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$3.96 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$3.59 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$3.16 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$1.96 Million1.96% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $35.9M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...